Nuvation Bio NUVB
$3.80 −$0.01 (-0.26%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $3.80 0.00%
Open$3.77
Prev close$3.81
Day range$3.72 – $3.91
Volume6.85M
Market cap$1.34B
P/E (TTM)–
Dividend yield–
NUVB Stock News
Headlines matching Nuvation Bio or the NUVB ticker, most recent first.
- Citi Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12
- J.P. Morgan Maintains Nuvation Bio(NUVB.US) With Buy Rating
- Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating
- Wedbush Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $11
- Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB), Nuvation Bio (NUVB) and ArriVent BioPharma, Inc. (AVBP)
- Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13
- B. Riley Securities Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $14 Positive
- A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $21
- Cantor Fitzgerald Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $12
- J.P. Morgan Initiates Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $13
- RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $19 Negative
- H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $21
- H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $21 Positive
- JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12
- RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $19
No comments yet — be the first to weigh in on NUVB.
Sign in to join the discussion.